Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sanofar J. Abdeen"'
Autor:
Adam S. Kinne, Erik J. Tillman, Sanofar J. Abdeen, Derrick E. Johnson, Elijah S. Parmer, Jacob P. Hurst, Brittany de Temple, Sherri Rinker, Timothy P. Rolph, Ronald R. Bowsher
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 232:115402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5205fa2b9bda41eabd25acfeab510cf0
https://doi.org/10.1016/j.jpba.2023.115402
https://doi.org/10.1016/j.jpba.2023.115402
Autor:
Jessica A Feauto, Aleks Davis, Richard C Delhaye, Sanofar J Abdeen, Hannah N Gill, Jamie E Colwell, Michael Chiappetta, Emma E Clor, Ronald R Bowsher
Publikováno v:
Bioanalysis. 14(12)
High-quality critical reagents are essential for the establishment of robust ligand binding assays to support regulated bioanalysis. To ensure consistency in assay performance over the lifetime of a project, a well-defined set of processes is needed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6adbe9734f709c428030633d9b77e91e
https://pubmed.ncbi.nlm.nih.gov/35904158
https://pubmed.ncbi.nlm.nih.gov/35904158
Autor:
Jian Zhou, Michael J. Martinez, Tohti Amet, Guangli Wang, Christina J. Miller, Brian K. Kay, James W. Van Huysse, Sanofar J. Abdeen, Ronald R. Bowsher, Jennifer E. McGinnis, Erica Simmons
Publikováno v:
New Biotechnology
A phage library displaying 1010 variants of the fibronectin type III (FN3) domain was affinity selected with the biotinylated form of the receptor binding domain (RBD, residues 319-541) of the SARS-CoV-2 virus spike protein. Nine binding FN3 variants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2f5f648a37e60036633c7b086a1889
Autor:
Ronald R. Bowsher, Elijah S Parmer, Timothy P Rolph, Adam S Kinne, Jennifer A Thystrup, Erik J. Tillman, Sanofar J. Abdeen
Publikováno v:
Journal of the Endocrine Society
Efruxifermin (EFX) is a novel Fc-fusion analog of human fibroblast growth factor 21 (FGF21), currently in clinical development as a potential treatment for non-alcoholic steatohepatitis (NASH). Each molecule of EFX consists of two modified FGF21 mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93251cf4787bbfe48475eaded3302150
https://doi.org/10.1210/jendso/bvab048.585
https://doi.org/10.1210/jendso/bvab048.585
Publikováno v:
ACS Chemical Biology. 5:1097-1103
Clostridium difficile causes severe hospital-acquired antibiotic-associated diarrhea due to the activity of two large protein toxins. Current treatments suffer from a high relapse rate and are generating resistant strains; thus new methods of dealing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747c6a0e2f703497403236166cbde17b
https://doi.org/10.1021/cb100209b
https://doi.org/10.1021/cb100209b